Patient Perception of Visual Distortions

November 18, 2015 updated by: Abbott Medical Optics
The purpose of this study is to evaluate visual distortions reported by pseudophakic patients.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

79

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Santa Ana, California, United States, 92705
        • Contact AMO for Trial Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Bilaterally-implanted pseudophakic subjects over 22 years of age with astigmatism who meet the inclusion criteria.

Description

Inclusion Criteria:

  • Corneal astigmatism of at least 0.75 diopters
  • Bilaterally-implanted with monofocal toric intraocular lenses in both eyes or with monofocal non-toric intraocular lenses in both eyes
  • At least one month postoperative from second-eye surgery
  • Ability to understand, read and write English to give consent and complete study questionnaire
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures and study visits
  • Sign informed consent and Health Insurance Portability and Accountability Act (HIPAA) authorization
  • Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

  • Any ocular pathology of clinical significance, as determined by the investigator, other than regular corneal astigmatism, that may affect visual outcomes or influence subjective ocular visual symptoms
  • Patient is pregnant or is lactating
  • Participation in any other clinical trial during the last 30 days prior to study enrollment or concurrent participation in any other ongoing clinical trial
  • Other protocol-defined exclusion criteria may apply

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pseudophakic implanted with toric IOL
Subjects bilaterally implanted with toric IOL
Pseudophakic implanted with non-toric IOL
Subjects bilaterally implanted with non-toric IOL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Distortion Symptoms
Time Frame: Baseline
Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.
Baseline
Visual Distortion Symptoms
Time Frame: 1 week
Subjective rating of visual distortion symptoms under overall conditions at baseline. Rating scale consisted of the following categories: "did not experience" (rating = 0), "mild" (rating = 1), "moderate" (rating = 2), or "severe" (rating = 3), therefore, the lower values represent the best outcome. The minimum score was 0 and the maximum score was 3.
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

July 10, 2014

First Submitted That Met QC Criteria

July 28, 2014

First Posted (Estimate)

July 30, 2014

Study Record Updates

Last Update Posted (Estimate)

December 22, 2015

Last Update Submitted That Met QC Criteria

November 18, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • TIOL-201-VPAS

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Administration of patient self-assessment

3
Subscribe